TITLE

International Stem Cell Discovers Method to Produce Uncontaminated Liver Cells: New Platform to Produce Various Cell Types Free From Undifferentiated, Potentially Tumorigenic, Cells

PUB. DATE
June 2011
SOURCE
Biomedical Market Newsletter;6/19/2011, p758
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the discovery of a technology by the scientists at International Stem Cell Corp. (ISCO) which helps produce liver cells uncontaminated with undifferentiated cells. It says that the starting materials for liver cells production are pluripotent stem cells, either human embryonic stem cells (hESCs) or proprietary human parthenogenetic stem cells (hpSCs) from ISCO. Andrey Semechkin, president of ISCO, states that the technology allows cell separation without any cell damage.
ACCESSION #
61997161

 

Related Articles

  • Intl Stem Cell Corp Completes $5 Mln Financing and Elects Jim Berglund to the Board of Directors.  // Biomedical Market Newsletter;3/14/2012, Vol. 21, p1 

    The article reports that International Stem Cell Corp. (ISCO) had obtained new capital financing of five million dollars in issued series of G Convertible Preferred Stock. It is mentioned that this financing was made by Andrey Semechkin, chief executive officer of ISCO. It further states that...

  • Intl Stem Cell Corp Announces 3rd Qtr 2011 Financial Results.  // Biomedical Market Newsletter;11/21/2011, Vol. 21, p789 

    The article reports on the 2011 third quarter financial performance of International Stem Cell Corp. (ISCO) which declares a revenue of 0.84 million dollars for the quarter. It states that increases in revenue was strongly motivated by strong sales from the initial launch of ISCO's wholly-owned...

  • International Stem Cell Corp Announces Changes to Streamline Management Team.  // Biomedical Market Newsletter;5/16/2011, p74 

    The article reports on the management changes at International Stem Cell Corp. (ISCO). It states that Brian Lundstrom has entered into a new contract which allows him to exclusively focus on therapeutic development and international partnering programs in areas outside the U.S. such as China and...

  • ISCO Scientists to Present Results of Recent Stem Cell Research on Central Nervous System and Liver Diseases at Annual Meeting of American Society of Gene and Cell Therapy.  // Biomedical Market Newsletter;5/17/2011, p565 

    The article focuses on the announcement of International Stem Cell Corp. (ISCO) that doctors Ruslan Semechkin and Nikolay Turovets will present the human parthenogenetic stem cells (HPSC) research at the 14th Annual Meeting of the American Society of Gene and Cell Therapy in Seattle, Washington....

  • A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes. Iwamuro, Masaya; Shiraha, Hidenori; Nakaji, Shuhei; Furutani, Masumi; Kobayashi, Naoya; Takaki, Akinobu; Yamamoto, Kazuhide // BioMedical Engineering OnLine;2012, Vol. 11 Issue 1, p93 

    Background: Bioartificial liver systems, designed to support patients with liver failure,are composed of bioreactors and functional hepatocytes. Immunological rejection of the embedded hepatocytes by the host immune system is a serious concern that crucially degrades the performance of the...

  • Gametogenesis in a dish. Gu, Ying; Liu, Guang-Hui; Belmonte, Juan Carlos Izpisua // Cell Research;Oct2012, Vol. 22 Issue 10, p1422 

    Recent progress in the induced pluripotent stem cell (iPSC) field as well as the establishment of germline stem cell isolation and culture methodologies may provide an in vitro platform for the study of physiological and pathological human gamete development and open new avenues for cell...

  • Long-term Culture of Human SSEA-4 Positive Spermatogonial Stem Cells (SSCs). Kokkinaki, Maria; Djourabtchi, Ardalan; Golestaneh, Nady // Journal of Stem Cell Research & Therapy;Special2012, Vol. 2 Issue S, Special section p1 

    Recently we and two other groups have shown that human spermatogonial stem cells (SSCs) have the potential to become pluripotent in vitro in defined culture conditions and to differentiate into cells of the three embryonic germ layers. This discovery could open new avenues for autologous...

  • A Comparative View on Human Somatic Cell Sources for iPSC Generation. Raab, Stefanie; Klingenstein, Moritz; Liebau, Stefan; Linta, Leonhard // Stem Cells International;2014, p1 

    The breakthrough of reprogramming human somatic cells was achieved in 2006 by the work of Yamanaka and Takahashi. From this point, fibroblasts are the most commonly used primary somatic cell type for the generation of induced pluripotent stem cells (iPSCs). Various characteristics of fibroblasts...

  • Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue. Heneidi, Saleh; Simerman, Ariel A.; Keller, Erica; Singh, Prapti; Li, Xinmin; Dumesic, Daniel A.; Chazenbalk, Gregorio // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Advances in stem cell therapy face major clinical limitations, particularly challenged by low rates of post-transplant cell survival. Hostile host factors of the engraftment microenvironment such as hypoxia, nutrition deprivation, pro-inflammatory cytokines, and reactive oxygen species can each...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics